- Home
- / Protea Biosciences Group
Protea Biosciences Group
Stock Price
$0
2020-04-27
Market Capitalization
$794
2020-04-27
Revenue
$2.4 M
FY, 2016
Protea Biosciences Group Summary
Company Summary
- Overview
- Protea is a molecular information company that has developed a platform technology, which enables the direct analysis, mapping and display of biologically active molecules in living cells and tissue samples.The technology platform offers new capabilities useful to the pharmaceutical, diagnostic, clinical research, agricultural and life science industries.
- Type
- Public
- Status
- Closed
- Founded
- 2001
- HQ
- Morgantown, WV, US | view all locations
- Website
- https://proteabio.com/
- Cybersecurity rating
Table of Contents
Key People
Leonard Harris, Board of Directors - Director
Stanley Hostler, Board of Directors - Director
Ed Roberson, Board of Directors - Director
LocationsView all
1 location detected
Morgantown, WV HQ
United States
1311 Pineview Dr #501
Protea Biosciences Group Financials
Summary Financials
- Revenue (Q2, 2017)
- $328.1K
- Gross profit (Q2, 2017)
- ($61.4K)
- Net income (Q2, 2017)
- ($5.5M)
- Cash (Q2, 2017)
- $82.7K
- EBIT (Q2, 2017)
- ($1.4M)
- Enterprise value
- $12.2M
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026